Volume 11 (2013): Issue 7 (Jul 2013)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xxiv–xxx
NCCN Guidelines® Updates
Pages: xxxii–xxxiii
Oncology Research Program
Pages: xxxvi
Practice Patterns and Guidelines-Based Treatments: A Renewed Call for Papers on Excellence in Cancer Care in Changing Times
By: Staff
Pages: 743
An Unusual Presentation of Chronic Myelogenous Leukemia: A Review of Isolated Central Nervous System Relapse
By: Scott M. Lindhorst, Richard D. Lopez, and Ronald D. Sanders
Pages: 745–750
Breast Cancer, Version 3.2013
By: Richard L. Theriault, Robert W. Carlson, Craig Allred, Benjamin O. Anderson, Harold J. Burstein, Stephen B. Edge, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford A. Hudis, Steven J. Isakoff, Britt-Marie E. Ljung, David A. Mankoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Lori J. Pierce, Elizabeth C. Reed, Lee S. Schwartzberg, Mary Lou Smith, Hatem Soliman, George Somlo, John H. Ward, Antonio C. Wolff, Richard Zellars, Dorothy A. Shead, and Rashmi Kumar
Pages: 753–761
Next-Generation Cancer Vaccine Approaches: Integrating Lessons Learned From Current Successes With Promising Biotechnologic Advances
By: Dung T. Le and Elizabeth M. Jaffee
Pages: 766–772
Systemic Therapy for Small Cell Lung Cancer
By: Benjamin Levy, Ashish Saxena, and Bryan J. Schneider
Pages: 780–787
Optimizing Systemic Therapy for Bladder Cancer
By: Sumanta K. Pal, Matthew I. Milowsky, and Elizabeth R. Plimack
Pages: 793–804
Gleason Scoring at a Comprehensive Cancer Center: What’s The Difference?
By: Natasha C. Townsend, Karen Ruth, Tahseen Al-Saleem, Eric M. Horwitz, Mark Sobczak, Robert G. Uzzo, Rosalia Viterbo, and Mark K. Buyyounouski
Pages: 812–819
The Case for Including Bowel Urgency in Toxicity Reporting After Pelvic Cancer Treatment
By: Caroline C. Henson, Carmel N. Anandadas, Lisa H. Barraclough, Ric Swindell, Catharine M.L. West, and Susan E. Davidson
Pages: 827–833
Myelodysplastic Syndromes
By: Peter L. Greenberg, Eyal Attar, John M. Bennett, Clara D. Bloomfield, Uma Borate, Carlos M. De Castro, H. Joachim Deeg, Olga Frankfurt, Karin Gaensler, Guillermo Garcia-Manero, Steven D. Gore, David Head, Rami Komrokji, Lori J. Maness, Michael Millenson, Margaret R. O’Donnell, Paul J. Shami, Brady L. Stein, Richard M. Stone, James E. Thompson, Peter Westervelt, Benton Wheeler, Dorothy A. Shead, and Maoko Naganuma
Pages: 838–874
The Multifaceted Nature of Myelodysplastic Syndromes: Clinical, Molecular, and Biological Prognostic Features
By: Peter L. Greenberg
Pages: 877–885
Cutting Edge: Flow Cytometry in Myelodysplastic Syndromes
By: Arjan A. van de Loosdrecht and Theresia M. Westers
Pages: 892–902
Are Centers and Practices Implementing Changes to Their Reimbursement or Payment Models? An NCCN Trends Report
By: Jake B. Guinto
Pages: 904–905
  • Collapse
  • Expand